{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1.57 vs. cons $1.53",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$4.39B vs. cons $4.37B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "NAST adjusted operating margin excluding restructuring (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~40.6% vs. cons 40.0%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted EPS framework",
      "prediction": "LOWER",
      "answer": "guide ~$6.00 vs. cons $6.12 (FY 2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Personnel expense",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.30B midpoint vs. cons $1.30B (FY 2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.5,
  "day5_path": "FADE",
  "day5_rationale": "Initial relief from an EPS beat and resilient NAST margin fades because the ~$6.00 FY2026 framework remains below the $6.12 consensus, implying softer second-half earnings versus Street math, while unresolved $604M litigation and capital-return risk limit multiple expansion.",
  "day5_confidence": "MEDIUM"
}